KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Cash from Financing Activities (2016 - 2025)

Jazz Pharmaceuticals has reported Cash from Financing Activities over the past 16 years, most recently at $75.4 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at $75.4 million for Q4 2025, up 1011.66% from a year ago — trailing twelve months through Dec 2025 was -$873.4 million (down 4357.07% YoY), and the annual figure for FY2025 was -$873.4 million, down 4357.07%.
  • Cash from Financing Activities for Q4 2025 was $75.4 million at Jazz Pharmaceuticals, up from -$10.8 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for JAZZ hit a ceiling of $4.7 billion in Q2 2021 and a floor of -$813.5 million in Q1 2025.
  • Median Cash from Financing Activities over the past 5 years was -$67.5 million (2023), compared with a mean of $114.1 million.
  • Biggest five-year swings in Cash from Financing Activities: plummeted 1953.24% in 2021 and later skyrocketed 1011.66% in 2025.
  • Jazz Pharmaceuticals' Cash from Financing Activities stood at -$246.6 million in 2021, then soared by 107.95% to $19.6 million in 2022, then crashed by 611.87% to -$100.3 million in 2023, then skyrocketed by 91.75% to -$8.3 million in 2024, then skyrocketed by 1011.66% to $75.4 million in 2025.
  • The last three reported values for Cash from Financing Activities were $75.4 million (Q4 2025), -$10.8 million (Q3 2025), and -$124.5 million (Q2 2025) per Business Quant data.